Rifnote Loading your desk
Story

Teva CEO on Drug Pipeline, Direct Listing on NYSE

Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE. (Source: Bloomberg)

July 29, 2026 World Bloomberg

Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg's Romaine Bostick about the company's positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE. (Source: Bloomberg)

Teva Pharmaceuticals CEO Richard Francis speaks to Bloomberg’s Romaine Bostick about the company’s positive Q2 earnings, the impending impact of changing Medicare rules on patients, and the new listing on the NYSE. (Source: Bloomberg)

This story was indexed from the original publisher. Read at Bloomberg

Leave a Reply

Your email address will not be published. Required fields are marked *